We found 15 drugmaker programs for Acute Myeloid Leukemia medicines. Tell us your insurance below and we'll show what to try first.
Help for Acute Myeloid Leukemia depends mostly on how you're covered. Pick the one that sounds like you. We'll name the funds and programs that fit, and what won't work, so you don't waste a phone call.
Copay cards lower what people with private insurance pay. Federal rules bar them for Medicare, Medicaid and TRICARE. Free medicine programs are for people without enough coverage and usually have income limits. We read each program on the drugmaker's own site.
Co-Pay Assistance for Pfizer oral oncology medicines: eligible commercially insured patients pay as little as $0 per month, up to $10,600 per product per year. Not for Medicare, Medicaid, TRICARE, VA or state programs.
Pfizer Patient Assistance Program provides Pfizer medicines free to eligible patients who have difficulty affording their Pfizer Oncology medicine.
Pfizer Oncology Together Care Champions help with insurance, financial assistance options and day-to-day resources. Call 1-877-744-5675.
The Pfizer Oncology Together page describes the oral co-pay tier without naming Daurismo.
Idamycin PFS (idarubicin) is on Pfizer RxPathways' list of available medications. The page does not say whether help is free drug or savings, or who qualifies. Call 1-844-989-PATH (7284) or use the Find a Program tool on pfizerrxpathways.com.
Eligibility and what is offered are not stated on the official page, so ask Pfizer RxPathways. Idarubicin is also sold as generics with no single manufacturer program. It is given in a clinic or hospital, so the hospital's financial counselor can also help.
BMS Access Support Co-Pay Assistance Program for eligible commercially insured patients; Idhifa is listed on the BMS co-pay page and its terms appear after selecting the medicine. Not for government insurance.
Bristol Myers Squibb Patient Assistance Foundation provides free medication to eligible uninsured patients experiencing financial hardship. Call 800-736-0003 or visit bmspaf.org.
BMS Access Support helps with benefits checks, prior authorizations and appeals and refers government-insured patients to independent charitable foundations. Monday to Friday, 8 AM to 8 PM ET.
The Idhifa co-pay dollar cap was not readable without selecting the medicine on the BMS site.
$0 Co-Pay Program for eligible patients with certain private insurance. Not valid for prescriptions reimbursed under Medicaid, a Medicare drug plan, TRICARE or other federal or state programs.
Assistance if your insurance does not fully pay for Inqovi; the page describes help for people whose coverage falls short and refers to the full criteria at taihopatientsupport.com.
Insurance checks, specialty pharmacy coordination, support for people with Medicare or other public insurance, and an optional nurse navigator who calls to talk through Inqovi. Enroll by phone at 1-844-TAIHO-4U or by fax with the Patient Enrollment Form.
Phone is 1-844-TAIHO-4U. The Inqovi page lists Blood Cancer United (1-800-955-4572) and AAMDSIF (1-800-747-2820) as advocacy resources.
KOMZIFTI Copay Card: eligible commercially insured patients pay as little as $0; ask the pharmacist for details. No annual cap is stated on the page.
Kura RxKonnect helps with insurance coverage so you do not have to work it out alone. Call 1-844-587-2777, Monday to Friday, 8 AM to 8 PM ET.
No free-drug program is described on Komzifti.com; status is partial until Kura publishes one or confirms there is none.
Co-Pay Assistance for certain Pfizer injectable or infused oncology medicines: eligible commercially insured patients pay as little as $0 per treatment, with a maximum benefit of $4,000 to $25,000 per calendar year depending on the product and no income requirement. Not for Medicare, Medicaid, TRICARE, VA or state programs.
Pfizer Patient Assistance Program provides Pfizer medicines free to eligible patients who have difficulty affording their Pfizer Oncology medicine, including some people with Medicare.
Pfizer Oncology Together Care Champions help with insurance, financial assistance options and day-to-day resources. Call 1-877-744-5675.
The Pfizer Oncology Together page describes program tiers without naming Mylotarg; the Mylotarg-specific maximum is in the co-pay portal terms.
BMS Access Support Co-Pay Assistance Program for eligible commercially insured patients; the Onureg-specific terms appear only after selecting the medicine on the BMS site. Not for Medicare, Medicaid, TRICARE, VA or other government coverage.
Bristol Myers Squibb Patient Assistance Foundation provides free medication to eligible uninsured patients experiencing financial hardship. Call 800-736-0003 or visit bmspaf.org.
BMS Access Support helps with benefits checks, prior authorizations and appeals and refers government-insured patients to independent charitable foundations. Monday to Friday, 8 AM to 8 PM ET.
Onureg.com points patients to BMS Access Support. The co-pay program's Onureg dollar cap was not readable without selecting the medicine on the BMS site.
Revuforj Copay Program: eligible commercially insured patients pay as little as $0 per prescription, with no income restrictions; maximum benefits may apply. Excludes cash-paying patients and Medicare Parts A to D, Medicaid, TRICARE, VA, DoD and other government programs.
SyndAccess nurses and insurance verification at 1-888-567-SYND (7963), Monday to Friday, 8 AM to 8 PM ET.
Phone is 1-888-567-SYND. Syndax's approval release says SyndAccess includes financial assistance for eligible patients, but no free-drug terms were published on the pages read, so none are listed.
Rezlidhia Copay Assistance: eligible patients with commercial insurance pay as little as $0 per prescription dispense. Eligibility requirements apply.
RIGEL ONECARE case managers connect with your insurance plan and care team, determine eligibility for copay and financial assistance programs and help with enrollment. Call 1-833-RIGELOC, Monday to Friday, 8 AM to 8 PM ET.
Rezlidhia.com mentions financial assistance beyond the copay program without describing it; no free-drug terms are listed until Rigel publishes them.
Novartis Oncology Universal Co-Pay Program: for patients with private insurance, with a combined annual limit up to $15,000. Not valid with Medicare, Medicaid, TRICARE, VA, DoD or other federal or state programs.
Copied from the existing midostaurin (mastocytosis) record checked October 12, 2026 so the AML page shows the same program. Novartis lists Rydapt among its co-pay products; the per-fill amount is not shown and a free-drug option is not listed until confirmed on Novartis's own pages.
Tibsovo Copay Program: eligible commercially insured patients pay as little as $0 per prescription; renewable for refills. Not valid for Medicaid, Medicare, Medigap, DoD, VA or TRICARE. No dollar cap is stated on the page.
QuickStart Program: eligible new patients facing a coverage delay of 5 or more business days may receive a prescription with an option for a refill, 60 days in total, once a prior authorization has been submitted. A Bridge Program is also listed.
Patient Assistance Program provides Tibsovo to uninsured and underinsured patients who meet eligibility criteria; the doctor's office faxes the enrollment form to 1-844-409-1143.
Patient Experience Managers at 1-800-813-5905, Monday to Friday, 8 AM to 8 PM ET, help with insurance and program enrollment.
The existing `ivosidenib` (cholangiocarcinoma) record points at tibsovo.com; this AML record uses the ServierONE Tibsovo page, which loaded on October 19, 2026. Servier customer service is 1-800-807-6124.
AccessCentral4U provides Daiichi Sankyo products, including Vanflyta, at no cost to eligible uninsured or underinsured patients.
Medication coverage and access support and financial assistance information through www.DSAccessCentral4U.com.
The Daiichi Sankyo patient assistance page gives no phone number or copay terms, and vanflyta.com did not load during this check. A copay program is not listed here until it is confirmed on a Daiichi Sankyo page.
Eligible commercially insured patients pay as little as $0 per prescription for Venclexta with azacitidine, decitabine or low-dose cytarabine, up to a $25,000 yearly limit. Not for Medicare, Medicare Advantage, Medigap, Medicaid, TRICARE, VA or other government insurance; a per-fill cap may apply if your plan uses a copay accumulator or maximizer.
AbbVie's nurse support line for Venclexta, (844) 926-6727, Monday to Friday, 7 AM to 7 PM Central, answers treatment questions at no cost (the nurses do not give medical advice).
myAbbVie Assist may provide AbbVie medicines at no cost to eligible US patients without insurance or with limited coverage; eligibility rules apply.
Venclexta is co-marketed by AbbVie and Genentech in the US, which is why the copay program is Genentech's. The Venclexta.com page has a tab for people with any insurance or no insurance whose content did not render in this check; it links to medicineassistancetool.org. Status is partial until that tab is read.
JazzCares Savings Card: eligible commercially insured patients may pay as little as $0 per prescription, subject to an annual maximum that the page does not state.
Patient Assistance Program: uninsured or underinsured patients who meet financial and residency criteria may receive Vyxeos at no cost.
Help understanding insurance coverage, other cost and coverage questions, and referrals to other financial assistance. Call 1-833-533-JAZZ, Monday to Friday, 8 AM to 8 PM ET; enrollment starts with a signed patient consent form.
Phone is 1-833-533-JAZZ (5299).
XOSPATA Patient Savings Program: eligible commercially insured patients pay as little as $0 per prescription, enrolled for 12 months, with a maximum of $7,000 per calendar year and no income requirement. Not for Medicaid, Medicare, Medigap, DoD, VA, TRICARE or state assistance programs; the benefit may drop to $25 per claim if your plan uses a maximizer or accumulator.
Astellas Patient Assistance Program provides Xospata at no cost to patients who are uninsured or whose insurance excludes it, have a US shipping address, are prescribed it for an FDA-approved use and meet financial criteria. The doctor's office submits the application.
Dedicated access specialists at 1-844-632-9272, Monday to Friday, 8 AM to 8 PM ET, for benefit verification, coverage questions and Medicare resources.
Copay enrollment is at XOSPATAcopayenroll.com.
The drugmaker doesn't publish an assistance program for this medicine. Cytarabine injection is an older generic sold by several manufacturers. No manufacturer assistance program was found. It is usually given in a clinic or hospital, so the hospital's financial counselor or social worker is the best place to ask about help with costs.
The drugmaker doesn't publish an assistance program for this medicine. Daunorubicin injection is an older generic sold by several manufacturers. No manufacturer assistance program was found. It is usually given in a clinic or hospital, so the hospital's financial counselor or social worker is the best place to ask about help with costs.
The drugmaker doesn't publish an assistance program for this medicine. Oral tretinoin (ATRA) capsules are sold as generics. No manufacturer assistance program was found. Ask your pharmacist about lower-cost generic sources, and ask your treatment center's financial counselor or social worker about help with costs.
The drugmaker doesn't publish an assistance program for this medicine. No patient assistance or savings program is listed on the official Trisenox site (Teva). Arsenic trioxide is also sold as generics. It is given in a clinic or hospital, so the hospital's financial counselor or social worker can help with costs.
Most of these programs start with one call, and having these ready makes it shorter. Tick them off as you go. Nothing here is saved or sent anywhere.
Call the drugmaker's support line first. Its case managers check your benefits and often fill out forms with your doctor. If a charity fund is closed, sign up on the foundation's page to hear when it reopens. Most programs need renewing every year, and many copay cards reset in January.
Yes. Trial Friend lists 15 drugmaker programs for Acute Myeloid Leukemia medicines. We checked every one at the source on or before October 19, 2026. Which ones fit depends on your insurance. Copay cards are for people with private insurance, charity funds usually need some insurance, and free medicine programs are for people without enough coverage.
No. Federal rules bar drugmaker copay cards for drugs paid by Medicare, Medicaid or TRICARE. For Acute Myeloid Leukemia, 0 charity funds on this page accept Medicare, and 2 drugmaker free medicine programs name Medicare patients among those who may qualify. In 2026, Medicare Part D also caps yearly out-of-pocket costs for covered drugs at $2,100.
Of the drugmaker programs for Acute Myeloid Leukemia medicines, 10 offer free medicine to people without insurance who qualify, usually with income limits. Most charity funds pay copays and premiums, so they need some insurance. The drugmaker's support line can also check whether you qualify for coverage you don't have yet.
How we check: drugmaker programs come only from each drugmaker's own pages. Fund status is copied from each foundation's list () on the date shown. Programs change, so confirm with the program before you rely on it. Trial Friend shares information, not financial, legal or medical advice, and each program decides who qualifies. See something wrong? Email jason@trialfriend.com.
